Yes, at $10 a share it would be a $1B valuation on 100M shares, but I am typically looking at the whole amount of shares that they can utilize (200M, but at minimum 130M...they'll probably dilute once they are past $1). Many stocks trade at 100x their projected revenues. The "beasts" like google and what not have hit 400x and even briefly 1000x if recall correctly. Penny shares quite frequently go 100x revenues with no problems as this isn't built out to it's full potential and in fact are usually just ramping up. If you go look around, the valuation of many micro caps are easily past even the 250x and some get ridiculously high (like biotechs) and in to 1000x as when they get caught up and stabilize they will be $20-$50 stocks. You must keep in mind that the "share price" is NOT a value as it is right this second for only it's current time value, but a certain portion of it is a "premium" based on its expected future value. It typically accounts for future growth. They 1) will open more non-franchise clinics, 2) will hopefully find more uses for their implant technology, 3) are already expanding into opiate addiction treatment, and 4) they are going to be able to negotiate with insurance companies for a higher fee when they are better known and prove beyond the shadow of a doubt that their way will help insurance companies save money in the long run by reducing the # and frequency of relapse.
Also, the jump to a more known exchange does not create extra value so much as help reassure people that their money is relatively safe. Thus, the share price will reflect an even longer projection (some companies have 15+ years built in to their stock price which to me is absurd).
And I actually am accounting for ALL available shares (i.e. 200M).
Plus, you are really really being too kind to penny stock investors and the human psyche / FOMO with "pumps". This stock will cross $1 with no problem. Sustainment of it will depend upon the moves the company makes as well as the total revenues. If for example, they get great results for opiate addiction and find other usages...then they will blow past $1 too.
Similar stocks are typically in the $8-12+ ranges on "real exchanges". You have to look at their total revenue growth over the next few years + all the press + the over valuation for the share price being so low and the high volatility it will have when it crosses the $1-2 range.
So, at no point did you understand where my projections were coming from to even come close to back a statement such as "but no where in your projects are you accounting for the float".
This is penny stock land and many people are momentum traders. When it gets momentum and has the safety of positive revenues with significant projected growth, it will sky rocket :)
